Mn Services Vermogensbeheer B.V. increased its position in shares of CME Group Inc. (NASDAQ:CME) by 509.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 55,133 shares of the financial services provider’s stock after buying an additional 46,083 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in CME Group were worth $6,905,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Guardian Life Insurance Co. of America raised its stake in CME Group by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock worth $156,000 after buying an additional 9 shares during the last quarter. Pitcairn Co. increased its position in CME Group by 0.4% in the first quarter. Pitcairn Co. now owns 3,247 shares of the financial services provider’s stock worth $386,000 after buying an additional 14 shares during the period. Buffington Mohr McNeal increased its position in CME Group by 0.3% in the first quarter. Buffington Mohr McNeal now owns 4,795 shares of the financial services provider’s stock worth $570,000 after buying an additional 15 shares during the period. Summit Asset Management LLC increased its position in CME Group by 0.5% in the first quarter. Summit Asset Management LLC now owns 3,016 shares of the financial services provider’s stock worth $358,000 after buying an additional 16 shares during the period. Finally, Assetmark Inc. increased its position in CME Group by 1.4% in the first quarter. Assetmark Inc. now owns 1,423 shares of the financial services provider’s stock worth $169,000 after buying an additional 19 shares during the period. 83.17% of the stock is owned by institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) traded up 1.16% during midday trading on Monday, reaching $122.69. The company’s stock had a trading volume of 253,143 shares. CME Group Inc. has a 52 week low of $98.95 and a 52 week high of $127.96. The stock has a market capitalization of $41.69 billion, a PE ratio of 26.56 and a beta of 0.74. The company has a 50 day moving average price of $123.81 and a 200-day moving average price of $120.41.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, April 27th. The financial services provider reported $1.22 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.02. The company had revenue of $929 million for the quarter, compared to analysts’ expectations of $932.06 million. CME Group had a net margin of 43.62% and a return on equity of 7.43%. The business’s revenue was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS. On average, equities research analysts expect that CME Group Inc. will post $4.86 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This article was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://stocknewstimes.com/2017/07/31/mn-services-vermogensbeheer-b-v-boosts-stake-in-cme-group-inc-nasdaqcme-updated.html.
A number of research firms have recently issued reports on CME. BidaskClub downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Friday. Jefferies Group LLC reiterated a “buy” rating and set a $134.00 target price (up from $128.00) on shares of CME Group in a research report on Monday, July 17th. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 target price on shares of CME Group in a research report on Friday, July 14th. Citigroup Inc. started coverage on CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price on the stock. Finally, Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $131.63.
In other CME Group news, CFO John W. Pietrowicz sold 2,500 shares of the firm’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $124.50, for a total value of $311,250.00. Following the completion of the transaction, the chief financial officer now directly owns 38,495 shares in the company, valued at $4,792,627.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Derek Sammann sold 2,100 shares of the firm’s stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $117.86, for a total transaction of $247,506.00. Following the completion of the transaction, the insider now owns 31,026 shares of the company’s stock, valued at $3,656,724.36. The disclosure for this sale can be found here. Insiders sold a total of 47,655 shares of company stock worth $5,829,020 in the last ninety days. Corporate insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.






